NFATC1 and B-cell chronic lymphocytic leukemia: As NFAT2 has been previously described to be significantly overexpressed and constitutively activated in CLL23, 24, 29, 30, we analysed patients with indolent and aggressive forms of CLL for the expression of this transcription factor (Fig. 1a–c).